Hypocholesterolemic effects of Chinese tea

Pharmacological Research

Volumn 35, Issue 6, 1997, Pages 505-512

  Yang, T T C ^a   Koo, M W L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Catechins; Hypercholesterolemia; Tea

Indexed keywords

CATECHIN; CHOLESTEROL; EPICATECHIN GALLATE; EPIGALLOCATECHIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ARTICLE; CHINESE HERB; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; LIPID STORAGE; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TEA;

EID: 0031172343     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0176     Document Type: Article

References (29)

1. 1. Wang ZH, Das M, Bickers DR, Mukhtar H. Interaction of epicatechins derived from green tea with rat hepatic cytochrome P-450. Drug Metab Disp 1988; 16: 98-103.
2. 2. Kada T, Kaneko K, Matsuzaki S, Matsuzaki T, Hara Y. Detection and chemical identification of natural bio-antimutagens. A case of the green tea factor. Mutation Res 1985; 150: 127-32.
3. 3. Ho CT, Chen QY, Huang S, Zhang KQ, Rosen RT. Antioxidative effect of polyphenol extract prepared from various Chinese teas. Prev Med 1992; 21: 520-5.
4. 4. Yoshino K, Hara Y, Sano M, Tomita I. Antioxidative effects of black tea theaflavins and thearubigin on lipid peroxidation of rat liver homogenates induced by tert-butyl hydroperoxide. Biol Pharm Bull 1994; 17: 146-9.
5. 5. Muramatsu K, Fukuyo M, Hara Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol 1986; 32: 613-22.
6. 6. Graham HN. Green tea composition, comsumption, and polyphenol chemistry. Prev Med 1992; 21: 334-50.
7. 7. Reaven GM, Laws A. Coronary heart disease in the absence of hypercholesterolemia. J Int Med 1990; 228: 415-7.
8. 8. Ando T, Nishimura T, Matsubayashi T, Ejiri H, Inoue K, Nakayama Y, Uchiyama S, Kakuda T, Mukai I. Effects of tea catechins on cholesterol absorption with exogenously hypercholesterolemic rats. Bull of Kanagawa dent Col. 1989; 17(1): 21-3.
9. 9. Sano M, Takenaka Y, Kojima R, Saito SI, Tomita I, Katou M, Shibuya S. Effects of pu-erh tea on lipid metabolism in rats. Chem Pharm Bull 1986; 34: 221-8.
10. 10. Olivier P, Plancke MO, Marzin D, Clavey V, Sauzieres J, Fruchart JC. Effect of fenofibrate, gemfibrozil and nicotinic acid on plasma lipoprotein levels in normal and hyperlipidemic mice: a proposed model for drug screening. Atherosclerosis 1988; 70: 107-14.
11. 11. Roeschlau P, Bernt E, Gruber W. Enzymatic determination of total cholesterol in serum. J Clin Chem Biochem 1974; 12: 403.
12. 12. Jacobs NJ, VanDemark PJ. α-Glycerophosphate oxidizing enzyme of Streptococcus fecalis 10C1. Arch Biochem Biophys 1960; 88: 250-5.
13. 13. Seigler L, Wu WT. Separation of serum high density lipoprotein for cholesterol determination: ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride. Clin Chem 1981; 27: 838-41.
14. 14. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
15. 15. Matsuda H, Chisaka T, Kubomura Y, Yamahara J, Sawada T, Fujimura H, Kimura H. Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles. J Ethnopharma 1986; 17: 213-24.
16. 16. Hofmann AF, Borgström B. The intraluminal phase of fat digestion in man. J Clin Incest 1964; 43: 247.
17. 17. Yamamoto M, Kumagai A, Yamamura Y. Structure and action of Saikosaponins isolated from Bupleurum falcatum L. Arzneim-Forsch. (Drug Res) 1975; 25: 1240-3.
18. 18. Umeda M, Amagaya S, Ogihara Y. Effect of shosaikoto, daisaikoto and sannoshashinto (traditional Japanese and Chinese medicines) on experimental hyperlipidemia in rats. J Ethnopharm 1989; 26: 255-69.
19. 19. Ikeda I, Imasato Y, Sasaki E, Nakayama M, Nagao H, Takeo T, Yayabe F, Sugano M. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 1992; 1127: 141-6.
20. 20. Shefer S, Hauser S, Bakersky I. Feedback regulation of bile acid biosynthesis in the rats. J Lipid Res 1969; 10: 646-55.
21. 21. Myant NB, Mitropoulos KA. Cholesterol 7α-hydroxylase. J Lipid Res 1977; 18: 135-53.
22. 22. Lee SY, Kim JD, Lee YH, Rhee HI, Choi YS. Influence of extract of Rosa Rugosa roots on lipid levels in serum and liver of rats. Life Sci 1991; 49: 947-51.
23. 23. Glomset JA. The plasma lecithin: cholesterol acyltransferase reaction. J Lipid Res 1968; 9: 155-67.
24. 24. Tall AR. Plasma high density lipoproteins metabolism and relationship to atherogenesis. J Clin Invest 1990; 86: 379-84.
25. 2+-mediated oxidative modification of low density lipoprotein. Biol Pharm Bull 1995; 18: 1-4.
26. 26. Stensvold I, Tverdal A, Solvoll, Foss OP. Tea consumption. Relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med 1992; 21: 546-53.
27. 27. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342: 1001-11.
28. 28. Yamaguchi Y, Hayashi M, Yamazoe H, Kunitomo M. Preventive effects of green tea extract on lipid abnormalities in serum, liver and aorta of mice fed an atherogenic diet. Nippon Yakurigaku Zasshi 1991; 97: 329-337.
29. 29. Sano M, Takahashi Y, Yoshino K, Shimoi K, Nakamura Y, Tomita I, Oguni I, Konomoto H. Effect of Tea (Camellia sinensis L.) on lipid peroxidation in rat liver and kidney: a comparsion of Green and Black tea feeding. Biol Pharm Bull 1995; 18: 1006-8.